Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McShane

Showing results (131-140 of 306) with videos related to

Pageof 31
Sort By:
Bioinformatics (Oxford, England)|November 9, 2002
Methods for assessing reproducibility of clustering patterns observed in analyses of microarray dataLisa M McShane, Michael D Radmacher, Boris Freidlin, et al.
Radiology|March 5, 2003
Dynamic US of the anterior band of the ulnar collateral ligament of the elbow in asymptomatic major league baseball pitchersLevon N Nazarian, John M McShane, Michael G Ciccotti, et al.
BMC Cancer|December 7, 2023
The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocolNouf Abutheraa, Emma-Louise Tarburn, Charlene M McShane, et al.
Experimental Oncology|July 14, 2006
Reporting recommendations for tumor marker prognostic studies (remark)L M McShane, D G Altman, W Sauerbrei, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1996
Surrogate end points in cancer research: a critiqueA Schatzkin, L S Freedman, J Dorgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
Reporting recommendations for tumor marker prognostic studiesLisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
Journal of the National Cancer Institute|August 18, 2005
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
Nature Clinical Practice. Oncology|September 1, 2005
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 27, 2021
Patient's perspectives of living with a precancerous condition: Monoclonal gammopathy of undetermined significance (MGUS)Blain Murphy, Charlene M McShane, Olinda Santin, et al.
Pageof 31

Showing results (131-140 of 306) with videos related to

Sort By:
Pageof 31
Bioinformatics (Oxford, England)|November 9, 2002
Methods for assessing reproducibility of clustering patterns observed in analyses of microarray dataLisa M McShane, Michael D Radmacher, Boris Freidlin, et al.
Radiology|March 5, 2003
Dynamic US of the anterior band of the ulnar collateral ligament of the elbow in asymptomatic major league baseball pitchersLevon N Nazarian, John M McShane, Michael G Ciccotti, et al.
BMC Cancer|December 7, 2023
The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocolNouf Abutheraa, Emma-Louise Tarburn, Charlene M McShane, et al.
Experimental Oncology|July 14, 2006
Reporting recommendations for tumor marker prognostic studies (remark)L M McShane, D G Altman, W Sauerbrei, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1996
Surrogate end points in cancer research: a critiqueA Schatzkin, L S Freedman, J Dorgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
Reporting recommendations for tumor marker prognostic studiesLisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
Journal of the National Cancer Institute|August 18, 2005
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
Nature Clinical Practice. Oncology|September 1, 2005
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 27, 2021
Patient's perspectives of living with a precancerous condition: Monoclonal gammopathy of undetermined significance (MGUS)Blain Murphy, Charlene M McShane, Olinda Santin, et al.
Pageof 31